Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.58 |
| ▸ | CES2 | O00748 | 3/20 | 0.58 |
| ▸ | CES1 | P23141 | 3/20 | 0.58 |
| ▸ | LMNA | P02545 | 3/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | PPARG | P37231 | 3/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | CNR2 | P34972 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6025145 | 1.00 | TSHR (0.58) | TSHRCES2CES1LMNAALDH1A1 | |
| SCHEMBL11490166 | 1.00 | TSHR (0.58) | TSHRCES2CES1LMNAALDH1A1 | |
| SCHEMBL2564553 | 1.00 | TSHR (0.58) | TSHRCES2CES1LMNAALDH1A1 | |
| SCHEMBL14845461 | 1.00 | TSHR (0.58) | TSHRCES2CES1LMNAALDH1A1 | |
| SCHEMBL9095301 | 0.98 | CES2 (0.57) | TSHRCES2CES1LMNAALDH1A1 | |
| SCHEMBL9095382 | 0.93 | CES2 (0.56) | TSHRCES2CES1LMNAALDH1A1 | |
| SCHEMBL16349103 | 0.91 | TDP1 (0.62) | TSHRCES2CES1LMNAALDH1A1 | |
| SCHEMBL13875402 | 0.91 | TDP1 (0.62) | TSHRCES2CES1LMNAALDH1A1 | |
| SCHEMBL14992716 | 0.88 | CES2 (0.50) | TSHRCES2CES1LMNAALDH1A1 | |
| SCHEMBL14992717 | 0.88 | CES2 (0.50) | TSHRCES2CES1LMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2822682-B1 | MICROCAPSULES AND USES THEREOF | FIRMENICH & CIE (CH) | 2017-04-26 | — | — | EP | claimed |
| US-9334464-B2 | Microcapsules and uses thereof | FIRMENICH SA (CH) | 2016-05-10 | — | — | US | claimed |
| EP-2822682-A1 | MICROCAPSULES AND USES THEREOF | Firmenich SA (CH) | 2015-01-14 | — | — | EP | claimed |
| US-20140323376-A1 | MICROCAPSULES AND USES THEREOF | FIRMENICH SA (CH) | 2014-10-30 | — | — | US | claimed |
| WO-2013079435-A1 | MICROCAPSULES AND USES THEREOF | FIRMENICH SA (CH) | 2013-06-06 | — | — | WO | claimed |
| EP-4711010-A2 | PRO-PERFUME COMPOSITIONS | Firmenich SA (CH) | 2026-03-18 | — | — | EP | disclosed |
| US-20250263631-A1 | PRO-PERFUME COMPOSITIONS | FIRMENICH SA (CH) | 2025-08-21 | — | — | US | disclosed |
| US-12325839-B2 | Pro-perfume compositions | FIRMENICH SA (CH) | 2025-06-10 | — | — | US | disclosed |
| US-12264295-B2 | Encapsulated pro-perfume compounds | FIRMENICH SA (CH) | 2025-04-01 | — | — | US | disclosed |
| US-20230093639-A1 | PERFUME SYSTEM FOR PERFUMED CONSUMER PRODUCT | FIRMENICH SA (CH) | 2023-03-23 | — | — | US | disclosed |
| US-20230032098-A1 | ENCAPSULATED PRO-PERFUME COMPOUNDS | FIRMENICH SA (CH) | 2023-02-02 | — | — | US | disclosed |
| US-20230024269-A1 | Pro-Perfume Compositions | FIRMENICH SA (CH) | 2023-01-26 | — | — | US | disclosed |
| WO-2021214205-A1 | PERFUME SYSTEM FOR PERFUMED CONSUMER PRODUCT | FIRMENICH SA (CH) | 2021-10-28 | — | — | WO | disclosed |
| WO-2021123144-A1 | PRO-PERFUME COMPOSITIONS | FIRMENICH SA (CH) | 2021-06-24 | — | — | WO | disclosed |
| WO-2020188079-A1 | ENCAPSULATED PRO-PERFUME COMPOUNDS | FIRMENICH SA (CH) | 2020-09-24 | — | — | WO | disclosed |
| EP-2822682-B1 | MICROCAPSULES AND USES THEREOF | FIRMENICH & CIE (CH) | 2017-04-26 | — | — | EP | disclosed |
| US-9334464-B2 | Microcapsules and uses thereof | FIRMENICH SA (CH) | 2016-05-10 | — | — | US | disclosed |
| EP-2822682-A1 | MICROCAPSULES AND USES THEREOF | Firmenich SA (CH) | 2015-01-14 | — | — | EP | disclosed |
| US-20140323376-A1 | MICROCAPSULES AND USES THEREOF | FIRMENICH SA (CH) | 2014-10-30 | — | — | US | disclosed |
| WO-2013079435-A1 | MICROCAPSULES AND USES THEREOF | FIRMENICH SA (CH) | 2013-06-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230093639-A1 | PERFUME SYSTEM FOR PERFUMED CONSUMER PRODUCT | PORCN, FAAH2, FASN | TSHR 4659/4885CES2 260/4885CES1 872/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.